Special Report: Race Oncology has initiated its lead trial site Southside Cancer Care Centre in Miranda, NSW, as the first ...

The new drug development corporation Daimbio announced on the 25th that it has completed a series A funding round worth 12 ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.

Disitamab vedotin, an antibody-drug conjugate (ADC), targets HER2-expressing cancer cells. It works by binding to HER2, being ...

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.

The dose of paclitaxel used in the new approach was 16-fold lower than that typically used in free paclitaxel, but with similar efficacy.

Seoul, South Korea Saturday, March 29, 2025, 14:00 Hrs [IST] ...

These cancers are, however, quite sensitive to anticancer drugs such as poly (ADP-ribose) polymerase inhibitors (PARPi). When successful, these cancer treatments cause enough DNA damage to trigger ...

Neoplastic Agents Market Report 2025" has been added to ResearchAndMarkets.com's offering.This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, ...

Created in 1992, the FDA's accelerated approval pathway allows an initial approval of drugs for serious or life-threatening ...